In Novo Nordisk’s legal fight against dozens of U.S. pharmacies and companies selling cheaper copies of its weight-loss drug ...

A Novo spokesperson said the Danish drugmaker was not ruling out further legal action after announcing new lawsuits against ...

Novo Nordisk has a commercial relationship with Economist Impact, a division of The Economist Group. The Economist operates ...

As a Barclays analyst put it, it’s been a “slow-moving car crash”. Early supply shortages pushed patients to competitors, ...

Novo Nordisk hit by slowing Ozempic sales, Tesla shareholders sue Musk over Robotaxi - Stock market news and latest business ...

COPENHAGEN (Reuters) -Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug ...

Denmark’s status as one of the few countries in Europe with an expanding economy rests in part on the success of its ...

Today's biotech news updates include rogue CAR-T treatment in Spain, halting illegal Wegovy sales, and Pfizer fumbling the bag.

(Reuters) -European shares edged higher and were on track for their biggest weekly gain in 12 as investors assessed U.S.

NEW YORK - August 8, 2025 ( NEWMEDIAWIRE) - Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S (NYSE: NVO) of a class action securities lawsuit.

First, Novo Nordisk, the company behind Ozempic and Wegovy, outgrew its native Denmark. Now, it’s bigger than Tesla. Shares in the pharmaceutical giant rose jumped more than 8% Thursday, pushing ...

Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit Wednesday, but rising competition ...